Vir Biotechnology, Inc. (VIR)
9.275
-1.02
(-9.86%)
USD |
NASDAQ |
May 07, 16:00
9.275
0.00 (0.00%)
After-Hours: 16:58
Vir Biotechnology SG&A Expense (TTM) : 92.07M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Hims & Hers Health, Inc. | 1.192B |
| Alnylam Pharmaceuticals, Inc. | 1.293B |
| BioMarin Pharmaceutical, Inc. | 946.91M |
| Gossamer Bio, Inc. | 37.63M |
| Sensei Biotherapeutics, Inc. | 9.056M |